<DOC>
	<DOCNO>NCT01141127</DOCNO>
	<brief_summary>The purpose study determine tranexamic acid plasma level child undergo cardiac surgery risk bleed compare two dose regimen .</brief_summary>
	<brief_title>Tranexamic Acid ( TXA ) Pediatric Cardiac Surgery</brief_title>
	<detailed_description>Tranexamic acid ( TXA ) administer intravenously prevent bleeding associate cardiac surgery pas adult child . The pharmacokinetic product unknown pediatric population . Only study report clinical efficacy different dosage . The purpose study determine plasma level TXA use two different administration method : continuous versus intermittent . The second objective determine whether fibrinolysis decrease . The population consist child weight 10 30 Kilos , undergo cardiac surgery high risk bleeding .</detailed_description>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>child weigh 10 30kg surgery cardiopulmonary bypass congenital heart disease deem hemorrhagic patient undergo surgical procedure short simple patient past history convulsion neurologiques especially allergy TA patient renal insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>tranexamic acid pediatric surgery</keyword>
	<keyword>fibrinolysis paediatric cardiac surgery</keyword>
</DOC>